bioRxivBiophysics
Polynuclear ruthenium amines inhibit K2P channels via a 'finger in the dam' mechanism
Abstract
The trinuclear ruthenium amine Ruthenium Red (RuR) inhibits diverse ion channels including K2P potassium channels, TRPs, the mitochondrial calcium uniporter, CALHMs, ryanodine receptors, and Piezos. Despite this extraordinary array, there is very limited information for how RuR engages its targets. Here, using X-ray crystallographic and electrophysiological studies of an RuR-sensitive K2P, K2P2.1 (TREK-1) I110D, we show that RuR acts by binding an acidic residue pair comprising the Keystone inhibitor site under the K2P CAP domain archway above the channel pore. We further establish that Ru360, a dinuclear ruthenium amine not known to affect K2Ps, inhibits RuR-sensitive K2Ps using the same mechanism. Structural knowledge enabled a generalizable RuR super-responder design strategy for creating K2Ps having nanomolar sensitivity. Together, the data define a finger in the dam inhibition mechanism acting at a novel K2P inhibitor binding site. These findings highlight the polysite nature of K2P pharmacology and provide a new framework for K2P inhibitor development.
- assay: electrophysiology
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Distinct mechanisms of inhibition of Kv2 potassium channels by tetraethylammonium and RY785
Shan Zhang, Robyn Stix, … José D. Faraldo‐Gómez·bioRxiv·Jul 25, 2024
- Extracellular modulation of TREK-2 activity with nanobodies provides insight into the mechanisms of K2P channel regulation
K. E. J. Rodstrom, A. Cloake, … S. J. Tucker·bioRxiv·Oct 19, 2023
- Development of covalent chemogenetic K2P channel activators
P. E. Deal, H. Lee, … D. L. Minor·bioRxiv·Oct 15, 2023
- Defining the Polycystin Pharmacophore Through HTS & Computational Biophysics.
Eduardo Guadarrama, Carlos G. Vanoye, Paul G. DeCaen·bioRxiv·Jan 13, 2025
- A regulatory domain in the K2P2.1 (TREK-1) carboxyl-terminal allows for channel activation by monoterpenes
Eden Arazi, Galit Blecher, Noam Zilberberg·Molecular and Cellular NeurosciencePeer-reviewed·Apr 19, 2020
- 4-methyl-3-aminopyridine: A novel active blocker of voltage-gated potassium ion channels in the central nervous system.
Sofia Rodríguez-Rangel, Oscar Gutiérrez Coronado, … Jorge E. Sánchez‐Rodríguez·NeuropharmacologyPeer-reviewed·Oct 7, 2026